Skip to main content

Table 1 Prevalence ratios (PR) and respective 95% confidence intervals (95% CI) obtained by multivariable Poisson regression, according to the hierarchical theoretical model for determining arterial hypertension

From: Prevalence of IGFBP3, NOS3 and TCF7L2 polymorphisms and their association with hypertension: a population-based study with Brazilian women of African descent

Variables

Level 1 PR (95% CI)

P

Level 2 *PR (95% CI)

P

Level 3 *PR (95% CI)

P

Level 4 PR (95% CI)

P

Level 1

Age group: 30.1–40

3.95 (2.46–6.34)

 < 0.001

3.95 (2.46–6.34)

 < 0.001

3.54 (2.20–5.69)

 < 0.01

3.36 (2.10–5.36)

 < 0.01

Age group: 40.1–50

8.06 (5.16–12.60)

 < 0.001

8.06 (5.16–12.60)

 < 0.001

7.33 (4.69–11.48)

 < 0.01

6.78 (4.35–10.59)

 < 0.01

Insertion in the formal labor market

1.18 (0.99–1.41)

0.050

1.18 (0.99–1.41)

0.051

1.17 (0.99–1.40)

0.06

*

*

Schooling level: ≤ 4 years

1.21 ( 0.99–1.48)

0.060

1.21 ( 0.99–1.48)

0.056

*

*

*

*

“Bolsa Família” Program: yes

1.20 (1.01–1.41)

0.037

1.20 (1.01–1.41)

0.037

1.15 (0.98–1.36)

0.094

1.12 (0.96–1.31)

0.156

Single register for social programs: yes

1.06 (0.78–1.44)

0.680

*

*

*

*

*

*

Level 2

Smoking

0.99 (0.77–1.13)

0.48

*

*

*

*

Level 3

BMI Overweight (≥ 25– < 30)

    

1.26 (0.98–1.61)

0.067

1.29 (1.02–1.64)

0.033

BMI Obesity (≥ 30)

1.63 (1.29–2.06)

 < 0.001

1.63 (1.29–2.06)

 < 0.001

Waist circumference ≥ 80 cm

1.02 (0.72–1.43)

0.091

 

*

Triglycerides ≥ 175 mg/dL

1.05 (0.88–1.26)

0.551

*

*

Total cholesterol ≥ 190 mg/dL

1.20 (0.96–1.49)

0.101

*

*

*LDL-C (mg/dL) ≥ 160 mg/dL

0.90 ( 0.73–1.12)

0.384

*

*

*HDL-C (mg/dL) > 50 mg/dL

1.27 (1.08–1.50)

0.003

1.24 (1.06–1.45)

0.007

Diabetes mellitus

1.28 (1.09–1.51)

0.003

1.16 (0.99–1.37)

0.060

Level 4

TCF7L2

CC

1

CT

1.04 (0.78–1.19)

0.623

TT

0.86 (0.69–1.06)

0.166

NOS3

GG

1

GT

0.95 (0.74–1.23)

0.755

TT

1.54 (1.27–1.86)

 < 0.001

IGFBP3

GG

1

AG

0.96 (0.78–1.19)

0.751

AA

1.59 (1.27–1.98)

 < 0.001

  1. LDL, low-density lipoprotein; HDL, high density lipoprotein; Prevalence ratios and respective 95% confidence intervals (95% CI)